reports
Fortiva® Retail Credit Announces Second Look Financing Program with By...
Fortiva® Retail Credit Announces Second Look Financing Program with Byte ATLANTA, April 17, 2024 (GLOBE NEWSWIRE) -- Atlanticus Holdings Corporation (NASDAQ: ATLC) (“Atlanticus”, “we” or “our”) today announced that a multi-year program with Byte, a leading at-home clear aligner provider was finalized with the Fortiva Retail Credit program, the leader in second look point-of-sale financing. The Fortiva Retail Credit program offers second look financing solutions that help businesses provide more consumers with access to goods and services. This partnership will provide a second look p...
- Budd Bugatch
1QFY24 Disappointing but Not Surprising; EPS of ($0.14), down $0.30 Y/...
Bassett’s 1QFY24 operating results disappointing, but not surprising. In its 2023 Annual Report, Bassett CEO Rob Spilman’s opening line was, “The other side of the COVID sales boom has proven to a rough ride for the home furnishings sector.” It remains challenging. Several untimely winter storms hit on important selling days, including the MLK holiday sale period. Moreover, comments from several other reporting companies noting the recent challenges underscore the recent malaise. Investors seem ...
NGM Bio Announces Closing of Tender Offer
NGM Bio Announces Closing of Tender Offer SAN FRANCISCO, April 05, 2024 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (“NGM Bio”) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announced that Atlas Neon Parent, Inc. (“Parent”), an affiliate of The Column Group, LP (“TCG”), through its wholly-owned subsidiary Atlas Neon Merger Sub, Inc. (“Merger Sub”), has successfully completed the previously announced cash tender offer to acquire all outstanding shares of NGM Bio not held by affiliates of TCG and certain oth...
Bassett Announces Fiscal First Quarter Results
Bassett Announces Fiscal First Quarter Results BASSETT, Va., April 03, 2024 (GLOBE NEWSWIRE) -- Bassett Furniture Industries, Inc. (Nasdaq: BSET) announced today its results of operations for its first quarter ended March 2, 2024. Fiscal 2024 First Quarter Highlights (Dollars in millions) Sales Operating Income (Loss) 1st Qtr Dollar% 1st Qtr% of 1st Qtr% of 2024 2023 ChangeChange 2024 Sales 2023 SalesConsolidated (1) $86.6 $107.7 $(21.1)-19.6% $(2.4)-2.8% $2.7 2.5% Wholesale $54.7 $69.9 $(15.2)-21.7% $6.8 12.4% $9.0 12.9% Retail $53.8 $65.0 $(11.2)-17...
NGM Bio to Present Two Posters Highlighting Clinical Data from the Ong...
NGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual Meeting SOUTH SAN FRANCISCO, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announced that two abstracts highlighting clinical data from the ongoing Phase 1/2 clinical trial of NGM707, a dual ILT2/ILT4 antagonist antibody product candidate, have be...
NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter...
NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results --Enrollment ongoing for patients with microsatellite stability (MSS) colorectal cancer (CRC) in Phase1/2 trial of NGM707, a dual ILT2/ILT4 antagonist antibody product candidate, in combination with KEYTRUDA® (pembrolizumab) with expected completion of enrollment in the second quarter of 2024-- --Announced ongoing toxicology activities intended to support initiation of a potential proof-of-concept study of NGM120, a GDF15/GFRAL antagonist, for the treatment of hyperemesis gravida...
Bassett Announces Regular Quarterly Dividend
Bassett Announces Regular Quarterly Dividend BASSETT, Va., March 07, 2024 (GLOBE NEWSWIRE) -- Bassett Furniture Industries, Inc. (Nasdaq: BSET) announced today that its Board of Directors has declared a regular quarterly dividend of $0.18 per share of common stock, payable on May 31, 2024, to shareholders of record at the close of business on May 17, 2024. About Bassett Furniture Industries, Inc.Bassett Furniture Industries, Inc. (NASDAQ:BSET), is a leading manufacturer and marketer of high quality home furnishings. With 89 company- and licensee-owned stores at the time of this release, ...
Atlanticus Reports Fourth Quarter and Full Year 2023 Financial Results
Atlanticus Reports Fourth Quarter and Full Year 2023 Financial Results Fourth Quarter 2023 Operating revenue growth of 14.9% over prior year, with 3.6 million accounts served (1), allowing for continued strong results Source: Atlanticus Holdings Corp ATLANTA, March 04, 2024 (GLOBE NEWSWIRE) -- Atlanticus Holdings Corporation (NASDAQ: ATLC) (Atlanticus, the Company, we, our or us), a financial technology company which enables its bank, retail and healthcare partners to offer more inclusive financial services to millions of everyday Americans, today announced its financial results for th...
NGM Bio Has Entered into a Definitive Agreement and Plan of Merger wit...
NGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LP NGM Bio stockholders to receive $1.55 per share in cash, an 80% premium over the closing share price on the last trading day prior to disclosure of receipt from The Column Group of a non-binding expression of interest in purchasing shares in a going-private transactionBased on a thorough exploration and review of strategic and financial alternatives, a Special Committee of independent and disinterested directors unanimously recommends the transaction SAN FRANCISCO, Feb. 26, 2...
NGM Bio to Participate in the Cowen 44th Annual Health Care Conference
NGM Bio to Participate in the Cowen 44th Annual Health Care Conference SOUTH SAN FRANCISCO, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announced that David J. Woodhouse, Ph.D., Chief Executive Officer, will participate in a corporate panel discussion on novel oncology targets at the Cowen 44th Annual Health Care Conference on Tuesday, March 5th, at 9:10 am ET. A live webcast of the presentation will be available under the Investors and M...
- Budd Bugatch
- Rex Henderson
Initiating Coverage of Bassett Furniture Industries, Inc.: A Survivor ...
We are initiating coverage of Bassett Furniture Industries, Inc. publicly traded under the ticker BSET. Bassett primarily operates in two segments: Retail and Wholesale. A third segment, Corporate & Other, accounts for corporate and unallocated expenses, as well as the operating results of Noa Home, a recent e-commerce acquisition. Bassett's Retail segment accounts for the results of 57 company-owned Bassett Home Furnishings stores (BHFs). For FYE November 2023, sales were ~$236MM (~60% of cons...
Atlanticus Closes Option in connection with Offering of Senior Notes
Atlanticus Closes Option in connection with Offering of Senior Notes ATLANTA, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Atlanticus Holdings Corporation (NASDAQ: ATLC) (“Atlanticus,” “the Company”, “we,” “our” or “us”), a financial technology company that enables its bank, retail and healthcare partners to offer more inclusive financial services to millions of everyday Americans, today announced the closing of the underwriters’ option in connection with its underwritten registered public offering (the “Offering”) of 9.25% Senior Notes due 2029 (the “Notes”). Atlanticus issued an additional 290,000...
Atlanticus Announces Approval of Quarterly Preferred Stock Dividend
Atlanticus Announces Approval of Quarterly Preferred Stock Dividend ATLANTA, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Atlanticus Holdings Corporation (NASDAQ: ATLC) (“Atlanticus,” the “Company,” “we” or “our”), a financial technology company that enables its bank, retail and healthcare partners to offer more inclusive financial services to millions of everyday Americans, today announced that its Board of Directors approved a quarterly dividend of $0.476563 per share to Series B Cumulative Perpetual Preferred shareholders. The cash dividend will be paid on or about March 15, 2024 to holders of re...
Atlanticus Closes $50 Million Offering of Senior Notes
Atlanticus Closes $50 Million Offering of Senior Notes ATLANTA, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Atlanticus Holdings Corporation (NASDAQ: ATLC) (“Atlanticus,” “the Company”, “we,” “our” or “us”), a financial technology company that enables its bank, retail and healthcare partners to offer more inclusive financial services to millions of everyday Americans, today announced the closing of its previously announced underwritten registered public offering (the “Offering”) of $50 million aggregate principal amount of 9.25% Senior Notes due 2029 (the “Notes”). The Offering resulted in net proc...
Atlanticus Prices $50 Million Offering of Senior Notes
Atlanticus Prices $50 Million Offering of Senior Notes ATLANTA, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Atlanticus Holdings Corporation (NASDAQ: ATLC) (“Atlanticus,” “the Company”, “we,” “our” or “us”), a financial technology company that enables its bank, retail and healthcare partners to offer more inclusive financial services to millions of everyday Americans, today announced the pricing of its underwritten registered public offering (the “Offering”) of $50 million aggregate principal amount of 9.25% Senior Notes due 2029 (the “Notes”). The Company has granted the underwriters a 30-day optio...
Bassett Announces Fiscal Fourth Quarter Results
Bassett Announces Fiscal Fourth Quarter Results BASSETT, Va., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Bassett Furniture Industries, Inc. (Nasdaq: BSET) announced today its results of operations for its fourth quarter ended November 25, 2023. Fiscal 2023 Fourth Quarter Highlights (Dollars in millions) Sales Operating Income (Loss) 4th Qtr Dollar% 4th Qtr% of 4th Qtr% of 2023 2022 ChangeChange 2023 Sales 2022 SalesConsolidated (1)$94.7$121.0 $(26.3)-21.7% $(4.5)-4.8% $6.7 5.5% Wholesale$60.6$74.6 $(14.0)-18.8% $8.4 13.9% $10.3 13.8% Retail$57.9$74.5 $(16.6)-22.3% ...
Atlanticus Announces Offering of Senior Notes
Atlanticus Announces Offering of Senior Notes ATLANTA, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Atlanticus Holdings Corporation (NASDAQ: ATLC) (“Atlanticus,” “the Company”, “we,” “our” or “us”), a financial technology company that enables its bank, retail and healthcare partners to offer more inclusive financial services to millions of everyday Americans, today announced it has commenced an underwritten registered public offering (the “Offering”) of Senior Notes due 2029 (the “Notes”). The Company expects to grant the underwriters a 30-day option to purchase additional Notes in connection with t...
NGM Bio to Participate in the B. Riley Securities 4th Annual Oncology ...
NGM Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference SOUTH SAN FRANCISCO, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announced that David J. Woodhouse, Ph.D., Chief Executive Officer, and Jean-Frédéric Viret, Ph.D., Chief Financial Officer, will participate in the B. Riley Securities 4th Annual Oncology Conference and will provide a business update focusing on NGM Bio’s wholly-owned oncology portfolio on Thursd...
Bassett Announces Regular Quarterly Dividend
Bassett Announces Regular Quarterly Dividend BASSETT, Va., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Bassett Furniture Industries, Inc. (Nasdaq: BSET) announced today that its Board of Directors has declared a regular quarterly dividend of $0.18 per share of common stock, payable on March 1, 2024, to shareholders of record at the close of business on February 16, 2024. About Bassett Furniture Industries, Inc.Bassett Furniture Industries, Inc. (NASDAQ:BSET), is a leading manufacturer and marketer of high quality home furnishings. With 87 company- and licensee-owned stores at the time of this rele...
NGM Bio Announces New Clinical Data from Ongoing Trial of NGM707 in Ad...
NGM Bio Announces New Clinical Data from Ongoing Trial of NGM707 in Advanced Solid Tumors and Outlines Evolved Strategy for Aldafermin and NGM120 to Focus on Rare Conditions with Significant Unmet Need Encouraging findings in heavily pretreated patients in multiple solid tumor indications, including MSS colorectal cancer (CRC), in ongoing Phase 1 Part 1b study evaluating NGM707, a dual ILT2/ILT4 antagonist antibody, in combination with KEYTRUDA® (pembrolizumab) Aldafermin, an engineered FGF19 analog, has been granted Orphan Drug Designation by the FDA for the treatment of primary sclerosin...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.